ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

GT Biopharma, Inc. · 2020
ClinicalTrials.gov · Datasets · License: Public Domain · 2020
Open Source ↗
high-risk myelodysplastic syndromes, acute myelogenous leukemia, systemic mastocytosis, mast cell leukemia, myelodysplastic syndromes (mds), acute myeloid leukemia (aml), interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 810075
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.